David G. Armstrong Recognized as the Recipient of the 2023 ACTS Distinguished Investigator Award for Translation from Proof of Concept to Widespread Clinical Practice

April 18, 2023

April 18, 2023 – the Translational Science Award recipients were honored by the Association for Clinical and Translational Science (ACTS), a non-profit membership association of translational scientists from the nation's top academic medical centers, at Translational Science 2023.

David G. Armstrong, DPM, MD, PhD, Professor of Surgery and Director of the Southwestern Academic Limb Salvage Alliance (SALSA) at the Keck School of Medicine of University of Southern California received the 2023 ACTS Distinguished Investigator Award for Translation from Proof of Concept to Widespread Clinical Practice. Dr. Armstrong is also President of the American Limb Preservation Society (ALPS). His work in limb preservation has prevented amputation in people with diabetes and prolonged lives worldwide.

ACTS presents annual Translational Science Awards to recognize outstanding contributions to the clinical research and translational science field. Individuals and teams are nominated by their colleagues and peers from all industry segments.

"The ACTS awards recognize talented investigators who translate their findings ultimately from the bench to the community," said ACTS President Linda B Cottler, PhD, MPH, FACE. "Awardees are in all phases of studies and disciplines throughout the workforce which includes investigators, trainees, educators, and research teams as well as the advancement of diversity, inclusion and health equity." The award winners and their work represent the values and mission of ACTS, and their achievements were celebrated at Translational Science 2023 in our nation's capital.

The ACTS Distinguished Investigator Award for Translation from Proof of Concept to Widespread Clinical Practice recognizes the senior investigator whose innovative research or education leadership has had a major impact on or through clinical and translational science, specifically in the realm of implementation and dissemination of translational solutions to illness and clinical problems.

# # #

The Association for Clinical and Translational Science (ACTS) uniquely provides an outstanding platform for enhancing education, research, and public policy related to clinical and translational science. ACTS members consist of leaders, investigators, and trainees from academic medical centers, government, industry, and philanthropy. ACTS focuses on four realms: research, education, advocacy, and mentoring. Additional information is available at the ACTS website at www.actscience.org.

The Southern California Clinical and Translational Science Institute (SC CTSI) is funded by the National Institutes of Health and serves as a multifaceted resource for clinical and community-partnered translational research. SC CTSI provides pilot funding, diverse training opportunities, robust clinical research support, digital recruitment methods, community connections, and many other tools to more than 1,000 investigators working at the University of Southern California, Children’s Hospital Los Angeles, the Los Angeles County Department of Health Services and in the communities of Los Angeles.

Watch Dr. Armstrong's acceptance speech below:

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.